MedTrace Logo

A Multicenter Registry of Adalimumab in Chinese Adult Patients With Active Ankylosing Spondylitis

NCT01901627 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2013-07-17

No results posted yet for this study

Summary

A multicenter registry to explore the clinical outcome of Chinese adult patients with active Ankylosing Spondylitis \*AS\* treated with adalimumab,prescribed according to the local label,in the real world practice

Conditions

  • Spondylitis, Ankylosing

Sponsors & Collaborators

  • Peking Union Medical College Hospital

    lead OTHER

Principal Investigators

  • Xiaofeng Zeng, MD · Peking Union Medical College Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01901627 on ClinicalTrials.gov